The disease phenotype reflects the distribution and severity of tau pathology in multiple tauopathies, including primary progressive aphasia, progressive supranuclear palsy, and corticobasal degeneration (Josephs et al., 2006). Here, MAPT is linked to primary progressive aphasia.